Multiple Ascending Dose Study in Subjects With Type 2 Diabetes
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and
pharmacodynamics following ascending multiple doses of AMG 876 in subjects with type 2
diabetes.